Compare tool

CJC-1295 (No DAC) vs Tesamorelin

Same attributes, same format, up to four peptides. Then let the advisor explain the trade-offs in plain language.

Peptide A

Anti-Aging & Longevity

Peptide B

Growth Hormone Optimization

Peptide C

Educational only, not medical advice.

AttributeCJC-1295 (No DAC)

Anti-Aging & Longevity

Tesamorelin

Growth Hormone Optimization

RouteSubcutaneousSubcutaneous
Dose range1 mg – 2 mg1 mg – 2 mg
FrequencyOnce per week (subcutaneous).Once per day (subcutaneous), preferably in the evening.
TimingEvening administration (pre-bed) may synergize with natural nocturnal GH release.Evening administration; rotate sites to reduce local irritation.
Cycle length8–12 weeks.12–26 weeks.
Vial options5 mg, 5 mg, 2 mg5 mg, 10 mg, 20 mg
Studied benefitsA GHRH analog that increases plasma GH levels by stimulating the pituitary gland. It is preferred for those who want a shorter half-life that mimics the body’s natural pulsatile release, leading to better fat metabolism and skin quality.Effectively reduces visceral (abdominal) fat and may improve lipid profiles. There is also emerging research regarding its potential to enhance cognitive function in older adults.
Reported side effectsOccasional "head rush" or flushing shortly after administration. Long-term use is generally well-tolerated with proper site rotation.Common side effects include joint pain, muscle aches, and mild swelling (edema). It may also lead to "carpal tunnel-like" symptoms (tingling in hands) and requires monitoring of blood sugar (HbA1c) and IGF-1 levels. Contraindicated in those with active malignancies.
Cited studies118
N1 Aminosfrom $55.00 →

Code DOSING15 · 15% off first order

from $69.00 →

Code DOSING15 · 15% off first order

CalculatorDo the mathDo the math

AI explanation

Click “Explain the trade-offs” for a plain-language read on mechanism, dosing scale, side-effect profile and research depth.

CJC-1295 (No DAC) vs Tesamorelin

Ask the advisor